NCT04661449 Effects of Lifestyle Intervention on Childhood Outcomes in LGA Infants
| NCT ID | NCT04661449 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
| Condition | Childhood Overweight |
| Study Type | INTERVENTIONAL |
| Enrollment | 138 participants |
| Start Date | 2021-01-22 |
| Primary Completion | 2023-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 138 participants in total. It began in 2021-01-22 with a primary completion date of 2023-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Large-for-gestational-age (LGA) infants have a higher risk of metabolic disease later in life, and their postnatal growth in early childhood may be associated with long-term adverse outcomes. The purpose of this study is to explore whether comprehensive lifestyle intervention in the first year after birth in LGA infants will reduce the rate of overweight/obesity at childhood and improve neurodevelopmental outcomes and its possible mechanism.
Eligibility Criteria
Inclusion Criteria: * term * large-for-gestational-age infants Exclusion Criteria: * major genetic disorder * congenital anomalies * severe digestive disease
Frequently Asked Questions
Who can join the NCT04661449 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 1 Month, studying Childhood Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04661449 currently recruiting?
Yes, NCT04661449 is actively recruiting participants. Visit ClinicalTrials.gov or contact Xinhua Hospital, Shanghai Jiao Tong University School of Medicine to inquire about joining.
Where is the NCT04661449 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04661449 clinical trial?
NCT04661449 is sponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. The trial plans to enroll 138 participants.